Alaunos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $14.1M | $109.1M | $79.7M |
| FY2020 | $22.4M | $146.3M | $115.1M |
| FY2021 | $36.8M | $94.9M | $76.1M |
| FY2022 | $26.4M | $64.9M | $39.1M |
| FY2023 | $2.0M | $8.3M | $6.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $14.1M | $109.1M | $79.7M |
| FY2020 | $22.4M | $146.3M | $115.1M |
| FY2021 | $36.8M | $94.9M | $76.1M |
| FY2022 | $26.4M | $64.9M | $39.1M |
| FY2023 | $2.0M | $8.3M | $6.1M |